Showing results (71-80 of 205) with videos related to
Sort By:
Pageof 21
Journal of Diabetes and Its Complications|October 21, 2015
Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery diseaseSha Li, Yan Zhang, Yuan-Lin Guo, et al.Cardiovascular Diabetology|October 24, 2021
Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosisHui-Wen Zhang, Jing-Lu Jin, Ye-Xuan Cao, et al.Current Medical Science|September 27, 2023
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Emergency Complex Higher-risk and Indicated PatientsZhi-Li Jin, Tao He, Li Peng, et al.Biomedical and Environmental Sciences : BES|March 2, 2017
Plasma apoCIII Levels in Relation to Inflammatory Traits and Metabolic Syndrome in Patients not Treated with Lipid-lowering Drugs Undergoing Coronary AngiographyNa Qiong Wu, Sha Li, Yan Zhang, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 30, 2011
Myocardial infarction caused by myocardial bridging in a male adolescent athleteCheng-Gang Zhu, Jun Liu, Wei-Dong Liu, et al.Scandinavian Journal of Clinical and Laboratory Investigation|February 26, 2014
Association of alkaline phosphatase with isolated coronary artery ectasiaQiao-Juan Huang, Yuan-Lin Guo, Cheng-Gang Zhu, et al.Chinese Journal of Integrative Medicine|May 14, 2015
Effects of Hedan Tablet () on lipid profile, proprotein convertase subtilisin/kexin type 9 and high-density lipoprotein subfractions in patients with hyperlipidemia: A primary studyRui-Xia Xu, Na-Qiong Wu, Sha Li, et al.Atherosclerosis|April 29, 2014
Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery diseaseSha Li, Yuan-Lin Guo, Rui-Xia Xu, et al.Postgraduate Medical Journal|July 19, 2019
Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort studyShuo-Lin Liu, Na-Qiong Wu, Yuan-Lin Guo, et al.Lipids in Health and Disease|June 3, 2014
Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable anginaLi-Feng Hong, Xiao-Lin Li, Yuan-Lin Guo, et al.Pageof 21